Ngā hua rapu - Lambert Busque

Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study mā Adi J. Klil-Drori, Hui Yin, Laurent Azoulay, Michaël Harnois, Michel-Olivier Gratton, Lambert Busque, Sarit E. Assouline

Whiwhi kuputuhi katoa

HTRS2025.P2.85 Sociodemographic disparities in thrombosis and bleeding rates in patients with myeloproliferative neoplasms: a real-world study from the Quebec MPN Research Group mā Sarah Côté-Denis, Lambert Busque, Sarah Côté-Denis, Michaël Harnois, Luigina Mollica, Harold Olney, Shireen Sirhan, Natasha Szuber

Whiwhi kuputuhi katoa

Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-... mā Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard, Timothy Devos, Francesco Passamonti, Wendy Y. Cheng, Mu Cheng, Marja Nuortti, Volker Baum, Claire Harrison

Whiwhi kuputuhi katoa

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group mā Alisa Poullet, Lambert Busque, Shireen Sirhan, Robert Delage, Ghislain Cournoyer, Ines Chamakhi, Danielle Talbot, Luigina Mollica, Daniele Marceau, Vincent Ethier, Pierre Desjardins, Harold J. Olney, Michaël Harnois, Natasha Szuber

Whiwhi kuputuhi katoa

Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study mā Lambert Busque, Marc-Étienne Beaudet, Michaël Harnois, Hanane Moussa, Natasha Szuber, Luigina Mollica, Robert Delage, Harold Olney, Pierre Laneuville, Ghislain Cournoyer, Inès Chamakhi, Marc Lalancette, Danielle Talbot, Vincent Ethier, Pierre Desjardins, Sarit Assouline

Whiwhi kuputuhi katoa

Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience mā Eva Laverdure, Luigina Mollica, Imran Ahmad, Sandra Cohen, Silvy Lachance, Olivier Veilleux, Maryse Bernard, Eve-Lyne Marchand, Jean-Sébastien Delisle, Lea Bernard, Mélissa Boileau, Tony Petrella, Sarah-Jeanne Pilon, Philippe Bouchard, Denis-Claude Roy, Lambert Busque, Isabelle Fleury

Whiwhi kuputuhi katoa

PB2681: GAPS IN THE ASSESSMENT AND MONITORING OF CARDIOVASCULAR RISK AND PSYCHOLOGICAL BURDEN IN POLYCYTHEMIA VERA: LANDMARK 2.0: A WORLDWIDE HEALTH SURVEY mā Claire Harrison, David Ross, Laura Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquín Martinez-Lopez, Alicia Rovó, Cheryl Petruk, Catalin Bobirca, Laura Mirams, Abigail Mcmillan, Gavin Harper, Jean-Jacques Kiladjian

Whiwhi kuputuhi katoa

Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey mā Claire N. Harrison, David M. Ross, Laura Maria Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian H. Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquin Martinez‐Lopez, Alicia Rovo, Cheryl Petruk, Catalin Bobirca, Laura Mirams, Abigail McMillan, Gavin Harper, Jean‐Jacques Kiladjian

Whiwhi kuputuhi katoa

P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES mā Michael Robert Savona, James K Mccloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary-Margaret Keating, Nancy Y Zhu, Nashat Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy Dezern, Casey L Oconnell, Gail Roboz, Lambert Busque, Rena Buckstein, Harshad Amin, Jasleen K Randhawa, Brian Leber, Kim-Hien Dao, Winny Chan, Aram Oganesian, Yuri Sano, Beloo Mirakhur, Harold Keer, Guillermo Garcia-Manero

Whiwhi kuputuhi katoa